Passage Bio logo
Passage Bio PASG
€ 7.22 2.74%

Geschäftsbericht 2025
hinzugefügt 03.03.2026

report update icon

Passage Bio Kurzfristige Verbindlichkeiten 2011-2026 | PASG

Kurzfristige Verbindlichkeiten Jährlich Passage Bio

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
23.1 M 19.4 M 16.3 M 18.4 M 29.5 M 21.2 M - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
29.5 M 16.3 M 21.3 M

Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Amgen Amgen
AMGN
25.5 B $ 350.13 2.98 % $ 188 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
882 M $ 12.73 3.33 % $ 3.99 B usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
73.4 M $ 1.48 8.82 % $ 394 M britainBritain
Applied Therapeutics Applied Therapeutics
APLT
71.2 M - - $ 8.42 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
130 M $ 24.57 5.59 % $ 3.13 B usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
CymaBay Therapeutics CymaBay Therapeutics
CBAY
36.8 M - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.68 4.28 % $ 16.8 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
70.6 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
49.6 M - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 3.05 0.66 % $ 6.64 B israelIsrael
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Cabaletta Bio Cabaletta Bio
CABA
50.2 M $ 3.05 -0.5 % $ 306 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
20.1 M - - $ 169 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
Cerus Corporation Cerus Corporation
CERS
101 M $ 1.93 4.62 % $ 368 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
16.1 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
81.1 M - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
1.33 M - -4.36 % $ 27 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
4.75 M $ 2.83 2.91 % $ 7.38 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
100 M - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
78.6 M - - $ 2.02 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
140 M $ 1.73 3.59 % $ 203 M usaUSA